Annual CFI
-$648.00 K
+$2.25 M+77.66%
December 31, 2024
Summary
- As of March 9, 2025, ARCT annual cash flow from investing activities is -$648.00 thousand, with the most recent change of +$2.25 million (+77.66%) on December 31, 2024.
- During the last 3 years, ARCT annual CFI has risen by +$2.76 million (+80.97%).
- ARCT annual CFI is now -102.93% below its all-time high of $22.13 million, reached on December 31, 2018.
Performance
ARCT Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$0.00
+$80.00 K+100.00%
December 31, 2024
Summary
- As of March 9, 2025, ARCT quarterly cash flow from investing activities is $0.00, with the most recent change of +$80.00 thousand (+100.00%) on December 31, 2024.
- Over the past year, ARCT quarterly CFI has increased by +$328.00 thousand (+100.00%).
- ARCT quarterly CFI is now -100.00% below its all-time high of $11.22 million, reached on March 31, 2018.
Performance
ARCT Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
-$648.00 K
+$875.00 K+57.45%
December 31, 2024
Summary
- As of March 9, 2025, ARCT TTM cash flow from investing activities is -$648.00 thousand, with the most recent change of +$875.00 thousand (+57.45%) on December 31, 2024.
- Over the past year, ARCT TTM CFI has increased by +$1.78 million (+73.27%).
- ARCT TTM CFI is now -102.14% below its all-time high of $30.32 million, reached on September 30, 2018.
Performance
ARCT TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
ARCT Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +77.7% | +100.0% | +73.3% |
| 3 y3 years | +81.0% | +100.0% | +87.1% |
| 5 y5 years | +20.8% | +100.0% | +87.1% |
ARCT Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +91.6% | -100.0% | +100.0% | at high | +91.6% |
| 5 y | 5-year | at high | +91.6% | -100.0% | +100.0% | at high | +91.6% |
| alltime | all time | -102.9% | +97.7% | -100.0% | +100.0% | -102.1% | +98.1% |
Arcturus Therapeutics Holdings Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$648.00 K(-77.7%) | $0.00(-100.0%) | -$648.00 K(-57.5%) |
| Sep 2024 | - | -$80.00 K(-75.6%) | -$1.52 M(-37.2%) |
| Jun 2024 | - | -$328.00 K(+36.7%) | -$2.42 M(-1.1%) |
| Mar 2024 | - | -$240.00 K(-72.6%) | -$2.45 M(-15.5%) |
| Dec 2023 | -$2.90 M(-62.5%) | -$875.00 K(-10.8%) | -$2.90 M(-50.3%) |
| Sep 2023 | - | -$981.00 K(+177.1%) | -$5.83 M(-17.1%) |
| Jun 2023 | - | -$354.00 K(-48.8%) | -$7.04 M(+11.6%) |
| Mar 2023 | - | -$691.00 K(-81.8%) | -$6.31 M(-18.4%) |
| Dec 2022 | -$7.73 M(+126.8%) | -$3.81 M(+74.2%) | -$7.73 M(+53.4%) |
| Sep 2022 | - | -$2.19 M(-678.3%) | -$5.04 M(+9.1%) |
| Jun 2022 | - | $378.00 K(-117.9%) | -$4.62 M(-14.5%) |
| Mar 2022 | - | -$2.11 M(+88.8%) | -$5.40 M(+58.5%) |
| Dec 2021 | -$3.41 M(+95.5%) | -$1.12 M(-36.7%) | -$3.41 M(+14.1%) |
| Sep 2021 | - | -$1.77 M(+337.1%) | -$2.98 M(+80.6%) |
| Jun 2021 | - | -$404.00 K(+242.4%) | -$1.65 M(-3.8%) |
| Mar 2021 | - | -$118.00 K(-83.1%) | -$1.72 M(-1.4%) |
| Dec 2020 | -$1.74 M(+113.0%) | -$697.00 K(+60.6%) | -$1.74 M(+28.1%) |
| Sep 2020 | - | -$434.00 K(-7.5%) | -$1.36 M(+25.3%) |
| Jun 2020 | - | -$469.00 K(+230.3%) | -$1.08 M(+23.0%) |
| Mar 2020 | - | -$142.00 K(-54.9%) | -$882.00 K(+7.8%) |
| Dec 2019 | -$818.00 K(-103.7%) | -$315.00 K(+98.1%) | -$818.00 K(-146.3%) |
| Sep 2019 | - | -$159.00 K(-40.2%) | $1.77 M(-81.9%) |
| Jun 2019 | - | -$266.00 K(+241.0%) | $9.75 M(-10.0%) |
| Mar 2019 | - | -$78.00 K(-103.4%) | $10.83 M(-51.1%) |
| Dec 2018 | $22.13 M | $2.27 M(-71.0%) | $22.13 M(-27.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2018 | - | $7.82 M(+857.5%) | $30.32 M(+35.3%) |
| Jun 2018 | - | $817.00 K(-92.7%) | $22.41 M(+57.3%) |
| Mar 2018 | - | $11.22 M(+7.4%) | $14.25 M(+37.6%) |
| Dec 2017 | $10.36 M(-1605.1%) | $10.46 M(<-9900.0%) | $10.36 M(-378.6%) |
| Sep 2017 | - | -$84.00 K(-98.9%) | -$3.72 M(-51.6%) |
| Jun 2017 | - | -$7.35 M(-200.2%) | -$7.68 M(-242.5%) |
| Mar 2017 | - | $7.33 M(-302.8%) | $5.39 M(-882.8%) |
| Dec 2016 | -$688.00 K(+212.7%) | -$3.62 M(-10.5%) | -$688.00 K(-107.7%) |
| Sep 2016 | - | -$4.04 M(-170.8%) | $8.96 M(-54.7%) |
| Jun 2016 | - | $5.71 M(+353.3%) | $19.79 M(+3.9%) |
| Mar 2016 | - | $1.26 M(-79.1%) | $19.05 M(-8760.0%) |
| Dec 2015 | -$220.00 K(-102.6%) | $6.03 M(-11.1%) | -$220.00 K(-123.2%) |
| Sep 2015 | - | $6.78 M(+36.3%) | $950.00 K(-275.3%) |
| Jun 2015 | - | $4.98 M(-127.6%) | -$542.00 K(-84.6%) |
| Mar 2015 | - | -$18.01 M(-350.1%) | -$3.53 M(-142.0%) |
| Dec 2014 | $8.41 M(-130.0%) | $7.20 M(+36.1%) | $8.41 M(-171.4%) |
| Sep 2014 | - | $5.29 M(+166.1%) | -$11.78 M(-58.1%) |
| Jun 2014 | - | $1.99 M(-132.7%) | -$28.13 M(-17.6%) |
| Mar 2014 | - | -$6.08 M(-53.2%) | -$34.12 M(+21.7%) |
| Dec 2013 | -$28.05 M(-2839.0%) | -$12.98 M(+17.3%) | -$28.05 M(+86.1%) |
| Sep 2013 | - | -$11.06 M(+176.4%) | -$15.07 M(+276.4%) |
| Jun 2013 | - | -$4.00 M(<-9900.0%) | -$4.00 M(<-9900.0%) |
| Mar 2013 | - | $0.00 | $0.00 |
| Dec 2012 | $1.02 M(-198.4%) | - | - |
| Dec 2011 | -$1.04 M | - | - |
FAQ
- What is Arcturus Therapeutics Holdings annual cash flow from investing activities?
- What is the all time high annual CFI for Arcturus Therapeutics Holdings?
- What is Arcturus Therapeutics Holdings annual CFI year-on-year change?
- What is Arcturus Therapeutics Holdings quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Arcturus Therapeutics Holdings?
- What is Arcturus Therapeutics Holdings quarterly CFI year-on-year change?
- What is Arcturus Therapeutics Holdings TTM cash flow from investing activities?
- What is the all time high TTM CFI for Arcturus Therapeutics Holdings?
- What is Arcturus Therapeutics Holdings TTM CFI year-on-year change?
What is Arcturus Therapeutics Holdings annual cash flow from investing activities?
The current annual CFI of ARCT is -$648.00 K
What is the all time high annual CFI for Arcturus Therapeutics Holdings?
Arcturus Therapeutics Holdings all-time high annual cash flow from investing activities is $22.13 M
What is Arcturus Therapeutics Holdings annual CFI year-on-year change?
Over the past year, ARCT annual cash flow from investing activities has changed by +$2.25 M (+77.66%)
What is Arcturus Therapeutics Holdings quarterly cash flow from investing activities?
The current quarterly CFI of ARCT is $0.00
What is the all time high quarterly CFI for Arcturus Therapeutics Holdings?
Arcturus Therapeutics Holdings all-time high quarterly cash flow from investing activities is $11.22 M
What is Arcturus Therapeutics Holdings quarterly CFI year-on-year change?
Over the past year, ARCT quarterly cash flow from investing activities has changed by +$328.00 K (+100.00%)
What is Arcturus Therapeutics Holdings TTM cash flow from investing activities?
The current TTM CFI of ARCT is -$648.00 K
What is the all time high TTM CFI for Arcturus Therapeutics Holdings?
Arcturus Therapeutics Holdings all-time high TTM cash flow from investing activities is $30.32 M
What is Arcturus Therapeutics Holdings TTM CFI year-on-year change?
Over the past year, ARCT TTM cash flow from investing activities has changed by +$1.78 M (+73.27%)